Subcellular distribution of receptor sites in human brain: differentiation between heavy and light structures of high and low density.
Studies of the subcellular localization of neuroreceptors in the rat brain have shown that most of them are associated with light and low density subcellular fractions. In two human brain areas, quite different subcellular distributions were observed. After fractionation by differential centrifugation of frontal cortex homogenates, benzodiazepine and serotonin 5-HT2 receptors were mainly found in the heavy mitochondrial (M) fraction, whereas mu-opiate and muscarinic cholinergic receptors were mainly concentrated in the microsomal (P) fraction. In human putamen, the presynaptic markers of dopaminergic nerve terminals (neurotensin receptors, dopamine uptake sites and amine vesicular transporter-binding sites), benzodiazepine receptors and serotonin uptake sites were recovered both in the high and low density fractions, whereas the muscarinic, opiate and, to a lesser extent, dopamine D2 receptors were mostly concentrated in the microsomal fraction. In the cerebral cortex, after isopycnic centrifugation in sucrose gradients, neuroreceptors were found in the high density fractions where the peaks of cytochrome oxidase and that of nerve endings, as identified by amine uptake and by means of electron microscopy were also found. A single peak of benzodiazepine receptors was observed in high density (1.15-1.17 g/ml) fractions suggesting that these receptors are much more concentrated in the nerve terminals or dendrites rather than in the dendritic spines or vesicles. The fact that muscarinic and opiate receptors were recovered in the P fraction with plasma membrane constituents and also in M and L fractions, which is confirmed by a bimodal distribution in sucrose gradient, suggests that they are localized in both the nerve terminals or dendrites and in the small vesicles or dendritic spines. In the putamen, much of the specific binding to uptake sites for dopamine and serotonin was recovered in the high density fractions, but the existence of another peak at a lower density indicates the presence of microsomal uptake sites. The results indicate that differential and isopycnic fractionation methods performed on human brain samples, make it possible to separate tissue fractions enriched in nerve endings, dendrites, dendritic spines, plasma membranes or vesicles.
Maloteaux
J M
JM
Department of Neurology (1080), Cliniques Universitaires St Luc, Université Catholique de Louvain (UCL), Brussels, Belgium.
Luabeya
M K
MK
Vanisberg
M A
MA
Jeanjean
A P
AP
Baudhuin
P
P
Scherman
D
D
Laduron
P M
PM
D001667:Binding, Competitive / Q000187:drug effects; D001921:Brain / Q000648:ultrastructure*; D001923:Brain Chemistry / Q000187:drug effects; D002500:Centrifugation, Isopycnic; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D003712:Dendrites / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D006801:Humans; D008854:Microscopy, Electron; D008875:Middle Aged; D009474:Neurons / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D017729:Presynaptic Terminals / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D011699:Putamen / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D011984:Sensory Receptor Cells / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure*; D013347:Subcellular Fractions / Q000187:drug effects / Q000378:metabolism*; D013378:Substantia Nigra / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D013572:Synaptic Vesicles / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D013574:Synaptosomes / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure
D011956:Receptors, Cell Surface